This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,127.16 firm fixed-price delivery order is for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, with a completion date of November 8, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is a part of that larger IDC. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Generated 2/6/25, 9:15 AM